Evidence map›Paper›PMID 27000861›Full record

ArticleDiagnostic pathology2016

Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study.

Ali DastranjTabrizi, Parvin MostafaGharabaghi, Farzam SheikhzadehHesari, Liela Sadeghi, Sharareh Zamanvandi, Parvin Sarbakhsh, Morteza Ghojazadeh

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ali DastranjTabriziWomen's Reproductive Health Research Center, Tabriz University of Medical Sciences-Iran, Tabriz, Iran.
Parvin MostafaGharabaghiWomen's Reproductive Health Research Center, Tabriz University of Medical Sciences-Iran, Tabriz, Iran.
Farzam SheikhzadehHesariDepartment of Physiology, Faculty of Science, Tabriz University-Iran, Tabriz, Iran. drhesari@gmail.com.
Liela SadeghiWomen's Reproductive Health Research Center, Tabriz University of Medical Sciences-Iran, Tabriz, Iran.
Sharareh ZamanvandiDepartment of Physiology, Faculty of Science, Tabriz University-Iran, Tabriz, Iran.
Parvin SarbakhshDepartment of Statistic and Epidemiology, Faculty of Nutrition and Health, Tabriz University of Medical Sciences-Iran, Tabriz, Iran.
Morteza GhojazadehWomen's Reproductive Health Research Center, Tabriz University of Medical Sciences-Iran, Tabriz, Iran.
Tabriz University of Medical Sciences · IRUniversity of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOvarian epithelial cancers are among the most lethal women's cancers. There is no doubt about the preventive role of oral contraceptive pills (OCPs) in development of ovarian cancers. But, there are limited numbers of studies to address the effect of these agents on the number of cortical inclusion cysts (CICs), their epithelial type and suppression of the metaplastic phenomenon by these pills. The aim of this study was to clarify the role of these agents in the prevention of these cyst formation and tubal metaplasia and also examine the mesenchymal-epithelial transition theory in this context by immunohistochemical methods.

methodsThe representative section(s) of ovarian cortex from a total number of 201 consecutive total abdominal hysterectomy with bilateral or unilateral salpingo-oophorectomy specimens were examined for mean number of CICs and their epithelial type between two groups of the patients. Group A included the patients who were on oral contraceptive pills for more than 5 years. All of the subjects with other contraceptive methods or a history of less than 5 years contraceptive pills usage were stratified in group B. Sections from 20 cases in which more than five inclusion cysts were found, were selected for IHC staining with calretinine and PAX8 as markers for mesothelium and mullerian epithelium respectively.

resultsThe mean age of the patients was 51.67 years with no significant differences between two groups. The mean number of cysts were 1.27 and 3.23 in group A and B respectively (P =0.0001). Similarly the mean number of CICs, lined by tubal epithelium, was significantly different between two groups (0.65 vs 2.65, P =0.0001). In IHC staining 123 out of 150 CICs (82 %) were PAX+ while only 7 CICs (4.8 %) showed positive reaction for calretinin irrespective of type of epithelium.

conclusionOur findings showed that the use of OCP for more than five years in women, significantly prevents development of cortical inclusion cysts in the ovaries which lined by tubal (PAX8 positive) type epithelium. These findings may explain the alternative mechanism of oral contraceptive pills or long time use of progesterone in suppression of tubal type overgrowth and subsequently prevention of ovarian epithelial cancers.

Indexed as

ImmunohistochemistryAdultAgedCalbindin 2Carcinoma, Ovarian EpithelialCellular MicroenvironmentContraceptives, Oral, HormonalDrug Administration ScheduleEpithelial CellsEpithelial-Mesenchymal TransitionFallopian TubesFemaleHumansMetaplasiaMiddle AgedNeoplasms, Glandular and EpithelialCALB2 protein, humanCalbindin 2Contraceptives, Oral, HormonalPaired Box Transcription FactorsPAX8 protein, humanPAX8 Transcription FactorOral contraceptive pillsOvarian cancerOvarian cortical inclusion cyst

Identifiers

PMID27000861
PMCPMC4802821
OpenAlexW2307176553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.